Breast Density into Clinical Practice

It is well established that breast density is related to breast cancer risk; making that connection precise, and understanding how to use it in clinical practice, has been a major academic focus since the 1970’s. However, it transpires that the first clinical uses of breast density have not been for risk prediction, rather they are for judging when to recommend further imaging. In this paper, we show how scientific research has had to be adapted in order to create the automated volumetric breast density assessment tool, Volpara®, to make it ready for actual clinical use and how it is impacting patient management.